What is the RIGL stock price prediction for next 2 weeks?

According to our price prediction algorithm,Rigel Pharmaceuticals, Inc. (RIGL) price will be around $31.56 in the next 2 weeks. This means it will increase by 9.200346020761256 from the last closing price. This prediction may vary from other time period filters for RIGL stock.

What can be the highest Possible price of RIGL stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, RIGL can achieve the highest price of $32.88 which is 13.786027770153089 higher than last closing price. This prediction may vary from other time period filters for RIGL stock.

What can be the lowest Possible price of RIGL stock in next 2 weeks?

As per the forecast and algorithmic analysis, RIGL stock price can be as low as $30.24 which is 4.647656332765509 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for RIGL stock.

Will RIGL stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that RIGL stock will gain9.200346020761256 in the next 2 weeks. This prediction may vary from other time period filters for RIGL stock.

What is RIGL stock last closing price?

Last closing price of RIGL stock was $28.90.

What is RIGL stock price prediction?

RIGL stock price prediction means predicting the future closing prices of RIGL stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of RIGL stock in a certain time period.

How we predict RIGL stock future prices?

If you are searching for RIGL stock forecast, analysis or price prediction, then you might be wondering what Rigel Pharmaceuticals, Inc. (RIGL) will do in the future. Our RIGL price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This RIGL price prediction will likely answer most of your questions.

How frequent we update RIGL stock predictions?

We are updating the forecasts for the RIGL stock on daily basis.

Is using ML forecasting for RIGL stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for RIGL stock same for all the time periods?

No, the prediction for RIGL stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Rigel Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$28.90-10.88%Since 2 Weeks

Predicted Price$31.569.2%For 2 Weeks

Upper Predicted Price$32.8813.79%For 2 Weeks

Lower Predicted Price$30.244.65%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of RIGL will rise by +9.20% over the next 2 Weeks and hit $31.56 by Thursday, May 14, 2026. In that time frame, RIGL's share price is expected to range between $30.24 and $32.88.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 14, 2026	30.24	31.56	32.88
May 13, 2026	29.90	31.11	32.48
May 12, 2026	29.96	31.28	32.58
May 11, 2026	29.44	30.74	32.04
May 8, 2026	29.07	30.33	31.68
May 7, 2026	29.14	30.42	31.77
May 6, 2026	28.65	29.97	31.25
May 5, 2026	28.91	30.14	31.52
May 4, 2026	28.39	29.60	30.88
May 1, 2026	27.90	29.19	30.52

RIGL shares rose +1.73% in Friday, May 1, 2026's trading session, rising from a previous close of $28.90 to move at $29.40. The stock demonstrated notable intraday movement (see RIGL's key stats for a full breakdown), fluctuating between $28.79 and $29.59, a +2.78% trading range. While recent weeks have seen some volatility, RIGL has managed to secure a -7.46% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 440.94K shares changing hands, 175.84K more than the previous session. This amounted to $12.96M in total market activity.

Will RIGL Continue Its Upward Trend?

According to analyst ratings and projections for RIGL, Rigel Pharmaceuticals, Inc. shares are anticipated to increase by +10.60%, potentially reaching $32.88 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for RIGL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the RIGL stock forecast, now is a good time to buy RIGL stock because its current trading price is -6.84% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on RIGL covering social and institutional perspectives.

RIGL Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into RIGL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.34% to 46.64%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.52%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.76%, maintains a neutral outlook for the long term. Insights into RIGL's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Rigel Pharmaceuticals Short-Term Forecasts

RIGL Forecast For Next 5 Days

Our algorithm anticipates Rigel Pharmaceuticals (RIGL) stock could hit $25.76 by May 08, 2026. This represents a -12.37% fall from today's price, following a -9.06% change over the past five days.

RIGL Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Rigel Pharmaceuticals, Inc. (RIGL) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $26.38, which would mean a -10.27% decrease from the current price of $29.40. Projections for this period range from a high of $33.23 to a low of $21.08.

RIGL Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Rigel Pharmaceuticals's price over the next three months point to a rise. RIGL stock is expected to peak at $34.83 on Jun 15, 2026 after potentially dipping to $25.33 on May 14, 2026. On average, RIGL is likely to trade around $30.35 in the coming 90 days.

Rigel Pharmaceuticals Stock Forecast 2025

Based on our predictive models, Rigel Pharmaceuticals (RIGL) is expected to trade between $25.33 and $44.38 throughout 2026. This would result in an average price of $31.64, potentially offering investors a +7.62% return from current levels.

Rigel Pharmaceuticals, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Rigel Pharmaceuticals, Inc. (RIGL) is positioned to show a strong performance in May 2026. The price is predicted to move between $25.33 and $32.50, settling at an average of $28.71. This could translate to a -2.35% loss.

June 2026

Based on current market signals, Rigel Pharmaceuticals, Inc. is projected to trend june 2026. We forecast a trading range from $28.00 to $34.83, with a likely average price of $31.32. Investors could expect a potential return of +6.53%.

July 2026

Our predictive algorithms indicate Rigel Pharmaceuticals, Inc. stock may see a shift in July 2026. The expected range spans $27.35–$34.25, with an average target of $30.85. This represents a positive outlook and a possible gain of +4.93%.

August 2026

Analyzing established trends, Rigel Pharmaceuticals, Inc. looks set to move in August 2026. Projections place the stock between $25.96 and $32.29, averaging around $28.78. This suggests a -2.11% loss from current levels.

September 2026

Market indicators suggest Rigel Pharmaceuticals, Inc. could experience notable changes during September 2026. Prices could fluctuate within $27.50 to $35.07, with a midpoint forecast of $31.56. The stock might deliver a +7.35% gain.

October 2026

Forecasting for October 2026, models estimate that Rigel Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $27.37 and $36.39, averaging $32.30. This signals a positive trajectory with potential returns around +9.86%.

November 2026

According to our latest forecast models, Rigel Pharmaceuticals, Inc. (RIGL) is positioned to show a strong performance in November 2026. The price is predicted to move between $31.38 and $44.38, settling at an average of $35.15. This could translate to a +19.56% gain.

December 2026

Based on current market signals, Rigel Pharmaceuticals, Inc. is projected to trend december 2026. We forecast a trading range from $30.08 to $37.77, with a likely average price of $34.10. Investors could expect a potential return of +15.99%.

January 2027

Our predictive algorithms indicate Rigel Pharmaceuticals, Inc. stock may see a shift in January 2027. The expected range spans $28.96–$35.81, with an average target of $32.32. This represents a positive outlook and a possible gain of +9.93%.

February 2027

Analyzing established trends, Rigel Pharmaceuticals, Inc. looks set to move in February 2027. Projections place the stock between $30.88 and $38.78, averaging around $35.14. This suggests a +19.52% gain from current levels.

March 2027

Market indicators suggest Rigel Pharmaceuticals, Inc. could experience notable changes during March 2027. Prices could fluctuate within $32.05 to $40.21, with a midpoint forecast of $35.89. The stock might deliver a +22.07% gain.

April 2027

Forecasting for April 2027, models estimate that Rigel Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $34.76 and $41.31, averaging $38.28. This signals a positive trajectory with potential returns around +30.20%.

RIGL's history of dividends and stock splits also plays a role in long-term investor confidence.